Children and young people have historically been excluded from participating in clinical research to protect them from potential harm. Nowadays, we know that it is essential to perform clinical trials with children because they suffer from diseases that adults do not suffer from and because their metabolism requires the right dose and mechanism of action for new treatments.
DetailsMental health has become less of a taboo topic in recent years and is considered as a part of our overall health. This change is thanks in part to an increase in mental health research and discussion in media. While this has led to great progress in diagnosis and treatment for such disorders in adults, tailored treatments are still lacking for children in this area.
DetailsThe c4c FAIR Data working group has collaborated with IMI project FAIRPlus to recommend steps for making metadata about paediatric clinical trials more FAIR (Findable, Accessible, Interoperable and Reusable).
DetailsOn the 17th and 18th of October 2023 Better medicines for children conference will be organized in Amsterdam!
DetailsThe colour of a product plays an important role in consumer experiences, and in the context of pharmaceutical products, this could potentially affect a patient’s expectations, behaviours, and adherence. Several studies have been conducted on adults, but little is known about children’s opinions on colours of medicines and to what extent medicines’ colour affects their…
Details
